加速人类健康和福祉的未来

Accelagen Pty Ltd has been instrumental in guiding our project from development through to clinical trial commencement. Their support, particularly in navigating the complex documentation requirements including a meticulous review and input on our clinical protocol has been invaluable. The project’s success is managed masterfully under the leadership of Project Manager. We have also benefited immensely from working closely with their specialised data management and statistical teams from the outset. This collaboration has allowed us to define our data capture strategy and ensure we best understand how to interpret our results at the end of the trial. Beyond their technical expertise, the entire Accelagen team is remarkably friendly, helpful, and consistently approachable. Their proactive communication style, including some valuable regulatory advice along the way, and advance notice of any foreseeable changes in scope, has transformed what is, in reality, a highly complex trial into a reachable reality. With the aim of ‘First Patient In’ in early 2026, this trial will be a game-changer, and Accelagen has truly made this crucial milestone possible.

As a small biotechnology company, we rely heavily on our CROs partners to provide expertise and support across the full scope of services required to conduct a successful clinical study from start up to close out. I have worked with the Accelagen team for nearly 3 years now on two separate, complex clinical studies conducted at multiple Australian sites. With each new challenge, I have found the team to be supportive, responsive, flexible and professional. I have no hesitation in recommending them as a CRO.

We have been working with Accelagen since March 2024 on a FIH study in Australia. We have been so impressed with their professionalism and service delivery that we decided to change CROs mid-way though our Phase IIa proof of concept study in the US. They are now they are that for us as well! Having worked for, and worked with various CROs, I rate Accelagen highly and wouldn’t hesitate to recommend them as a great option to running your study.

Working with the Accelagen team has been a very positive experience for us. The team is hands-on and sensitive to our needs. As a virtual biopharmaceutical company, having a partner like Accelagen that treats us with the same priority as a larger client makes an important difference in the success of our clinical trial programs in Australia.

全程支持和指导。当我们作为合同研究组织与Accelagen合作时，我们不确定如何最大限度地提高开发计划的成果。幸运的是，他们的团队能够支持和指导我们设定实现公司目标的道路。

与Accelagen合作在帮助我们开辟一条通往市场批准的明确途径方面发挥了重要作用。我对团队指导我们完成整个过程并一直帮助我们取得成功的结果都不为过！

我们之所以联系Accelagen，是因为我们需要额外的资源来完成我们的项目。在他们的帮助和建议下，我们得以完成成功获得上市批准所需的必要任务。